BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 17624996)

  • 1. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
    Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
    Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism.
    Glanz J; Grant B; Monteiro M; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Jul; 26(7):1047-61. PubMed ID: 12170115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational interviewing with hazardous drinkers.
    Beckham N
    J Am Acad Nurse Pract; 2007 Feb; 19(2):103-10. PubMed ID: 17300536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in heavy drinking as a treatment outcome in alcohol dependence.
    Gastfriend DR; Garbutt JC; Pettinati HM; Forman RF
    J Subst Abuse Treat; 2007 Jul; 33(1):71-80. PubMed ID: 17588491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does participation in an alcohol administration study increase risk for excessive drinking?
    Pratt WM; Davidson D
    Alcohol; 2005 Nov; 37(3):135-41. PubMed ID: 16713501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dexfenfluramine in the treatment of alcohol dependence.
    Romach MK; Sellers EM; Kaplan HL; Somer GR; Gomez-Mancilla B
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1534-41. PubMed ID: 11045862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readiness to change problematic drinking assessed in the emergency department as a predictor of change.
    Leontieva L; Horn K; Haque A; Helmkamp J; Ehrlich P; Williams J
    J Crit Care; 2005 Sep; 20(3):251-6. PubMed ID: 16253794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readiness for change and readiness for help-seeking: a composite assessment of client motivation.
    Freyer J; Tonigan JS; Keller S; Rumpf HJ; John U; Hapke U
    Alcohol Alcohol; 2005; 40(6):540-4. PubMed ID: 16186144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: three-month drinking outcomes.
    Brown RL; Saunders LA; Bobula JA; Mundt MP; Koch PE
    Alcohol Clin Exp Res; 2007 Aug; 31(8):1372-9. PubMed ID: 17550366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage of change and decisional balance for women seeking alcohol treatment.
    Share D; McCrady B; Epstein E
    Addict Behav; 2004 May; 29(3):525-35. PubMed ID: 15050671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study.
    Anton RF; Youngblood M
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1878-83. PubMed ID: 17067352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do brief measures of readiness to change predict alcohol consumption and consequences in primary care patients with unhealthy alcohol use?
    Williams EC; Horton NJ; Samet JH; Saitz R
    Alcohol Clin Exp Res; 2007 Mar; 31(3):428-35. PubMed ID: 17295727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study.
    Salloum IM; Cornelius JR; Douaihy A; Kirisci L; Daley DC; Kelly TM
    Addict Behav; 2005 Oct; 30(9):1702-8. PubMed ID: 16098680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
    Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
    Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.